Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Concerns over "tasteless and, possibly, harmful" advertising of amphetamines and other prescription drugs in the US are raised in an article published on bmj.com.
Dr Sidney Wolfe, founder and senior adviser to the Health Research Group at Public Citizen, describes how a Los Angeles boutique is selling athletic shirts emblazoned with the word "Adderall" - a prescription amphetamine for treating attention-deficit/hyperactivity disorder (ADHD).
Although Shire, the manufacturer of Adderall, says it is "gravely" concerned that the use of Adderall on the shirts "glorifies the misuse and diversion of a federally controlled prescription drug, Wolfe points out that the company "has been pulled up by the FDA for overstating the benefits of its product in its own direct to consumer advertising campaign."
This included a webpage and a YouTube video overstating the efficacy of Adderall XR, and omitting important risk information about the drug. Neither the webpage nor the video appears any longer on the internet.
Wolfe explains that direct to consumer prescription drug advertising in print advertisements and on television is currently only allowed in the United States and in New Zealand, "which probably influences manufacturers' conduct online."
Unfortunately, Europe has considered allowing it, he adds. And he agrees with opponents of direct to consumer advertising for prescription drugs that "its wider introduction would lead to a 'pharma knows best' culture."
Author: Sidney M Wolfe
BMJ 2013; 347 doi: http://dx.doi.org/10.1136/bmj.f6215 (Published 17 October 2013)
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Alcohol / Addiction / Illegal Drugs category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
BMJ. "Senior doctor raises concern over advertising of some prescription drugs in the US." Medical News Today. MediLexicon, Intl., 21 Oct. 2013. Web.
12 Dec. 2013. <http://www.medicalnewstoday.com/releases/267670>
BMJ. (2013, October 21). "Senior doctor raises concern over advertising of some prescription drugs in the US." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/267670.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.